Professor at Aristotle University of Thessaloniki, Greece
 Profiles
👨‍🔬 Academic Background
Theodoros Sklaviadis is an esteemed Emeritus Professor at the Department of Pharmacognosy-Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, Greece. With over 30 years of experience in academia and research, he has made significant contributions to the study of neurodegenerative diseases, particularly prion diseases. Dr. Sklaviadis has held prominent roles, including Professor and Head of the Department of Pharmacognosy-Pharmacology, where he has guided numerous research projects and contributed extensively to scientific literature.
🎓 Education
Dr. Sklaviadis holds a Ph.D. in Biochemistry from Aristotle University of Thessaloniki (1980-1984), where he conducted research on the purification and properties of ornithine decarboxylase from Tetrahymena pyriformis. He also earned a B.Sc. in Pharmacy from the same institution (1974-1979).
đź’Ľ Professional Experience
Throughout his illustrious career, Dr. Sklaviadis has served in various prestigious roles. He is currently an Emeritus Professor at Aristotle University of Thessaloniki (2023-present). Previously, he was a Professor (2008-2023) and Head of the Department (2021-2023) of Pharmacognosy-Pharmacology at the same university. He also held positions as an Adjunct Professor at Rockefeller University in New York (2011-2015), an Associate Professor at Aristotle University of Thessaloniki (1993-2008), an Assistant Professor at Yale University, USA (1988-1993), and a Post-Doctoral Associate in Neuropathology at Yale University (1984-1987).
🔬 Research Interests
Dr. Sklaviadis’s research is centered on the pathogenesis and treatment of neurodegenerative disorders, with a particular focus on prion diseases and Alzheimer’s disease. His work explores genetic and molecular mechanisms, biomarker identification, and the development of innovative therapeutic strategies. Through collaborative networks and groundbreaking research, Dr. Sklaviadis aims to advance understanding and treatment of these complex conditions.
Fellowships & Awards 🏆
Dr. Sklaviadis was a partner in the Joint Programming Neurodegenerative Disease Research project from 2012 to 2015, focusing on biomarkers for neurodegenerative diseases. He has received awards for his outstanding contributions, including a 1st Prize at the 67th Panhellenic Conference of the Hellenic Society for Biochemistry and Molecular Biology in 2016.
Research & Scientific Activities 🔬
Dr. Sklaviadis has published 78 papers and contributed one book chapter. His work has garnered over 4,189 citations, reflecting an H-index of 34 and an i10-index of 70. His research focuses on neurodegenerative disorders, with significant contributions to understanding and combating prion diseases and other neurological conditions.
đź“–Â Publication
RNA editing regulates glutamatergic synapses in the frontal cortex of a molecular subtype of Amyotrophic Lateral Sclerosis
-
- Authors: Karagianni, K., Dafou, D., Xanthopoulos, K., Sklaviadis, T., Kanata, E.
- Journal: Molecular Medicine
- Year: 2024
SIMOA Diagnostics on Alzheimer’s Disease and Frontotemporal Dementia
-
- Authors: Chatziefstathiou, A., Canaslan, S., Kanata, E., Sklaviadis, T., Dafou, D.
- Journal: Biomedicines
- Year: 2024
Αnti-prion effects of anthocyanins
-
- Authors: Christoudia, N., Bekas, N., Kanata, E., Dafou, D., Sklaviadis, T.
- Journal: Redox Biology
- Year: 2024
A Comparison of RML Prion Inactivation Efficiency by Heterogeneous and Homogeneous Photocatalysis
-
- Authors: Paspaltsis, I., Kanata, E., Sotiriadis, S., Xanthopoulos, K., Sklaviadis, T.
- Journal: Pathogens
- Year: 2024
Gene targeting in amyotrophic lateral sclerosis using causality-based feature selection and machine learning
-
- Authors: Founta, K., Dafou, D., Kanata, E., Gounaris, A., Xanthopoulos, K.
- Journal: Molecular Medicine
- Year: 2023